Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.

Jeffrey R Strawn; Scott N Compton; Brigitte Robertson; Anne Marie Albano; Mohamed Hamdani; Moira A Rynn

doi:10.1089/cap.2016.0132

Publisher Website

Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.

Authors

Strawn, Jeffrey R¹
Compton, Scott N²
Robertson, Brigitte³
Albano, Anne Marie⁴
Hamdani, Mohamed³
Rynn, Moira A⁵

¹ 1 Anxiety Disorders Research Program, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine , Cincinnati, Ohio.
² 2 Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine , Durham, North Carolina.
³ 3 Shire , Lexington, Massachusetts.
⁴ 4 New York State Psychiatric Institute, Columbia University , New York, New York.
⁵ 5 New York Presbyterian Morgan Stanley Children's Hospital, Columbia University/New York State Psychiatric Institute, New York, New York.

Type

Published Article

Journal

Journal of Child and Adolescent Psychopharmacology

Publisher

Mary Ann Liebert

Publication Date

Feb 06, 2017

Identifiers

DOI: 10.1089/cap.2016.0132

PMID: 28165762

Source

Medline

Keywords

License

Unknown

Abstract

GXR was well tolerated in pediatric subjects with GAD, SAD, and/or social anxiety disorder. ClinicalTrials.gov Identifier: NCT01470469.

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. This record was last updated on 07/07/2017 and may not reflect the most current and accurate biomedical/scientific data available from NLM. The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/28165762

Report this publication

Statistics

Seen <100 times